Atypical ductal breast hyperplasia
Atypical ductal hyperplasia
Atypia
Atypical glandular cells
Atypical hyperplasia
Atypical lobular hyperplasia
Atypical mole
Atypical squamous cells of undetermined significance
Atypical squamous cells, cannot exclude a high-grade lesion
Atypical teratoid/rhabdoid tumor
Auditory
Auditory brain stem response test
Augmentin
Augmerosen
Auricular
Auricular acupuncture
Aurimmune
Aurora B/C kinase inhibitor GSK1070916A
Aurora kinase inhibitor AT9283
Aurotherapy

Would COVID-19 vaccine protect people of all ages?

Coronavirus outbreak largest study suggests elderly and sick are most at risk

The explanation for the generally heightened risk to the elderly, but also for the fact that Covid-19 kills many younger people even as some seniors survive, lies in a growing understanding of “immunosenescence.” Immunologists have identified some of the specific ways the immune system changes with age, allowing them to go beyond the simple assertion that it weakens.

“Older people are not as good at reacting to microorganisms they haven’t encountered before,” said physician and immunobiologist Janko Nikolich-Zugich of the University of Arizona College of Medicine. He calls it “the twilight of immunity.” [Source

]

Our immune systems have two sets of defenses against viruses and other pathogens: a first-line army of cells, called leukocytes, that attack invading microbes within minutes to hours, and a second-line force of precisely targeted antibodies and T cells that surge to the battle front as late as several days after.

It will, almost inevitably, be less successful in older people, because aged immune systems do not respond as well to immunisation.

It may be possible to overcome this by either giving multiple doses or giving it alongside a chemical (called an adjuvant) that gives the immune system a boost.

ALSO SEE:  Coronavirus (COVID-19) Vaccine Stages Before Approval

Leave a Reply

Your email address will not be published. Required fields are marked *